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ABSTRACT
We present a case of a 65 years old man from Islamabad who presented with six months history of psychiatric and 
behavioural symptoms, significant weight loss. Later on he developed difficulty swallowing and altered sensorium. This 
was followed by an episode of shortness of breath leading to respiratory arrest, followed by ICU stay on ventilator 
support, then developed focal deficit in form of left sided weakness, dysautonomia, bradycardia leading to cardiac 
arrest and another cardiopulmonary resuscitation, myoclonic jerks, orofacial dyskinesias, status epilepticus, coma 
ultimately resulting in death of the patient. Patient was found to be NMDA receptor antibody positive. CT chest and 
abdomen did not reveal any hidden malignancy. Patient was given intravenous pulse steroids for 5 days followed by 
five sessions of plasmapheresis but did not respond. He stayed on ventilator support for 40 days and did not improve. 
This is the second case of antibody proven NMDA encephalitis from Pakistan, the first being from Islamabad as well 
and published in this journal.
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INTRODUCTION
NMDARs basically are ligand-gated ion channels which 
are major mediators of excitatory neurotransmission. 
Antibodies to the NMDAR (the main target being the 
NR1 subunit) were initially described in a 
paraneoplastic encephalitis associated with ovarian 
teratomata, with neurological symptoms presented 
prior to tumour diagnosis (range, 1–380 weeks).1,2
The first symptoms are usually psychiatric, behavioural 
disturbances and seizures, with clinical worsening over 
10–20 days to generate dyskinesias (orofacial 
grimacing, dystonic posturing and choreoathetoid 
movements), autonomic instability and reduced 
consciousness, often requiring ventilatory support3,4 
The two-stage progression of these symptoms may 
involve cortical and subcortical functions3,4
We report a case of an elderly male with similar 
classical presentation of neurosychiatric manifestations 
followed by hypoventilation, respiratory and bulbar 
paralysis, focal deficit and refractory seizures.
CASE REPORT
A 66 years old male presented with history of 
depressive and behavioural symptoms for six months 
for which various antidepressants were given. There was 
history of significant weight loss in past six months with 
decreased appetite and reduced oral intake. He also 
used some unknown homeopathic medications during 
this period. He was brought to emergency with one 
week history of depressed conscious level, difficulty in 
breathing, difficulty in swallowing. On examination he 
was found to be dehydrated, low BP, GCS was 8/15, gag 
reflex was absent but there was no focal neurological 
deficit. Initial investigations showed low Sodium and 
Potassium. He was intubated and Potassium was 
replaced. Thiamine and glucose was also given. His CT 
scan brain was normal. His MRI brain could not be done 
as he was on ventilatory support. His CSF examination 
showed increased proteins of 72mg/dl with normal 
cells. His echocardiogram was normal. His EEG showed 
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Brain MRI is unremarkable in 50% of the cases1. If 
abnormal, it usually shows increased signals in FLAIR 
and T2 sequences in cerebral, cerebellar or medial 
temporal lobes1
If abnormalities are present, they are either seen 
cortically (usually in the limbic mediotemporal 
cortex)1,6,7 or subcortically in the brainstem, the basal 
ganglia, or the cerebellum.2,3 Rarely, T2 and FLAIR 
hyperintensities or contrast enhancement (in cortical 
meninges or basal ganglia) are detected2
MRI brian could not be done in our patient as he stayed 
on ventilator support throughout the hospital stay. CT 
scan brain done twice in our patient was normal.
CSF usually reveals nonspecific changes8as seen in our 
patient. EEG often reveals diffuse delta slowing without 
paroxysmal discharges,5,9,
Paraneoplastic cases are infrequent in children3,4,10 and 
are very unusual in men3. All paraneoplastic workup 
was negative in our patient.
In previous studies it has been that patients do seem to 
benefit from aggressive immunotherapy3,4 Patients may 
recover completely or be left with residual cognitive 
impairment and usually all have amnesia for the events 
of the cute illness3,4 Our patient however did not 
improve and died.
CONCLUSION
NMDA encephalitis has a recognizable pattern of 
presentation but can have a lethal course and 
poor prognosis especially in elderly.
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diffuse encephalopathy as shown in figure 1. Autoimmune vs Paraneoplastic encephalitis was suspected. His CT chest 
abdomen and pelvis was done to rule out malignancy but were unremarkable
Figure 1.EEG of of the patient suggestive of diffuse 
encephalopathy.
After 03 days of ICU stay he developed sudden 
asystole, became pulseless and BP less, CPR was done 
for eight  minutes. He revived. He started to improve 
GCS improved to 11/15 but he developed left sided 
weakness along with some focal fits on right side and 
orofacial dyskinesias. CT scan brain was repeated 
which again was unremarkable as shown in figure 2.
Figure 2. CT scan brain of the patient which was 
normal.
He started having seizures. He was loaded with 
Phenytoin, injectable valproate and levitiracetam were 
also given in appropriate doses but fits continue to 
increase, meanwhile he was started on midazolam 
infusion for refractory status epilepticus. During this 
period further workup was done including anti neuronal 
antibodies, autoimmune profile, anti GAD antibodies. 
His NMDA receptor antibodies came back positive and 
was given pulse steroids for 05 days. He did not show 
any improvement and was started on plasmapheresis. 
He had another episode of bradycardia leading to 
asystole and another CPR was done for 10 min. He 
revived but GCS remained 3/15 post CPR and there 
was high suspicion of hypoxic ischemic brain damage 
post CPR. He was however given complete five sessions 
of plasma exchange with no improvement. He stayed 
on ventilator support for around 40 days in vegetative 
state. Weaning off trials from ventilator support were 
attempted but were not successful. Finally, support was 
withdrawn on wishes of family and patient died.
DISCUSSION
This syndrome is a severe encephalopathy that 
generally follows a characteristic temporal sequence of 
features3 as was seen in our patient. Patients may 
present with a constellation of symptoms including 
psychiatric symptoms5, memory disturbances, seizures, 
dyskinesia and catatonia5
In adults, the neuropsychiatric features almost always 
precede presentation of movement disorders, 
autonomic dysfunction, or reduced consciousness by 
about 10 days or more3 , same was the case in our 
patient.
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